Document is current

Any future updates will be listed below

Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

Crossref DOI link: https://doi.org/10.1186/s40337-023-00926-5

Published Online: 2023-11-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark